Penumbra, Inc. (PEN)
323.79
-1.39
(-0.43%)
USD |
NYSE |
Aug 24, 16:00
323.79
0.00 (0.00%)
After-Hours: 20:00
Penumbra Net Income (Quarterly) : 34.81M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 34.81M |
| March 31, 2026 | 32.58M |
| December 31, 2025 | 47.34M |
| September 30, 2025 | 45.85M |
| June 30, 2025 | 45.27M |
| March 31, 2025 | 39.22M |
| December 31, 2024 | 33.68M |
| September 30, 2024 | 29.53M |
| June 30, 2024 | -60.20M |
| March 31, 2024 | 11.00M |
| December 31, 2023 | 54.22M |
| September 30, 2023 | 9.214M |
| June 30, 2023 | 18.96M |
| March 31, 2023 | 8.562M |
| December 31, 2022 | 3.877M |
| September 30, 2022 | -2.271M |
| June 30, 2022 | -3.687M |
| March 31, 2022 | 0.079M |
| December 31, 2021 | -24.63M |
| September 30, 2021 | 8.031M |
| June 30, 2021 | 8.299M |
| March 31, 2021 | 10.93M |
| December 31, 2020 | 2.632M |
| September 30, 2020 | -9.876M |
| Date | Value |
|---|---|
| June 30, 2020 | -12.90M |
| March 31, 2020 | 0.888M |
| December 31, 2019 | 9.301M |
| September 30, 2019 | 11.00M |
| June 30, 2019 | 16.25M |
| March 31, 2019 | 10.45M |
| December 31, 2018 | 6.464M |
| September 30, 2018 | -22.43M |
| June 30, 2018 | 13.38M |
| March 31, 2018 | 5.491M |
| December 31, 2017 | 9.083M |
| September 30, 2017 | 0.238M |
| June 30, 2017 | -1.558M |
| March 31, 2017 | -3.106M |
| December 31, 2016 | -2.396M |
| September 30, 2016 | 11.91M |
| June 30, 2016 | 3.013M |
| March 31, 2016 | 2.291M |
| December 31, 2015 | 1.633M |
| September 30, 2015 | 0.901M |
| June 30, 2015 | -0.537M |
| March 31, 2015 | 0.503M |
| June 30, 2014 | 0.075M |
| March 31, 2014 | 0.28M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Boston Scientific Corp. | 905.00M |
| Globus Medical, Inc. | 151.57M |
| Abbott Laboratories | 928.00M |
| AngioDynamics, Inc. | -11.40M |
| Teleflex, Inc. | 41.76M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 390.05M |
| Total Expenses (Quarterly) | 355.24M |
| EPS Diluted (Quarterly) | 0.8797 |
| Enterprise Value | 12.36B |
| Gross Profit Margin (Quarterly) | 66.50% |
| Profit Margin (Quarterly) | 8.92% |
| Earnings Yield | 1.26% |
| Operating Earnings Yield | 1.47% |
| Normalized Earnings Yield | 1.258 |